Skip to main content

Oral Submucous Fibrosis

  • Chapter
  • First Online:
Contemporary Oral Oncology

Abstract

Oral submucous fibrosis (OSF) is a chronic, insidious disease characterised by progressive submucosal fibrosis of the oral cavity and the oropharynx. The disease sometimes extends to the pharynx and upper third of the oesophagus. As the disease progresses, the resulting loss of fibroelasticity and stiffening of the oral mucosa leads to limitation in opening of the mouth of affected individuals. The presence of fibrous bands in lips, cheeks and soft palate is a hallmark of the disease [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Tilakaratne WM, Ekanayaka RP, Warnakulasuriya S. Oral submucous fibrosis: a historical perspective and a review on aetiology and pathogenesis. Oral Surg Oral Med Oral Pathol. 2016;122(2):178–91.

    Google Scholar 

  2. Schwartz J. Atrophia idiopathica (tropica) mucosae oris. Demonstrated at the 11th international dental congress, London; 1952.

    Google Scholar 

  3. Joshi SG. Submucous fibrosis of the palate and the pillars. Indian J Otolaryngol. 1953;4:1–4.

    Google Scholar 

  4. Lal D. Diffuse oral submucous fibrosis. J All India Dent Assoc. 1953;26:1–3.

    Google Scholar 

  5. Pin SI. Idiopathic scleroderma of the mouth. Arch Otolaryngol. 1954;59:330–2.

    Google Scholar 

  6. Paymaster JC. Cancer of the buccal mucosa; a clinical study of 650 cases in Indian subjecs. Cancer. 1956;9:431–5.

    CAS  PubMed  Google Scholar 

  7. Pindborg JJ, Chawla TN, Srivastava AN, Gupta D, Mehrotra ML. Clinical aspects of oral submucous fibrosis. Acta Odontol Scand. 1964;22:679–91.

    CAS  PubMed  Google Scholar 

  8. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol. 1966;22:764–79.

    CAS  PubMed  Google Scholar 

  9. Pindborg JJ, Mehta FS, Daftary DK. Occurrence of epithelial atypia in 51 Indian villagers with oral submucous fibrosis. Br J Cancer. 1970;24:253–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Pindborg JJ. Is submucous fibrosis a pre-cancerous condition in the oral cavity? Int Dent J. 1972;22:474–80.

    CAS  PubMed  Google Scholar 

  11. Pindborg JJ, Bhonsle RB, Murti PR, Gupta PC, Daftary DK, Mehta FS. Incidence and early forms of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol. 1980;50:40–4.

    CAS  PubMed  Google Scholar 

  12. Pindborg JJ. Oral submucous fibrosis: a review. Ann Acad Med. 1989;18:603–7.

    CAS  Google Scholar 

  13. Meghji S, Warnakulasuriya S. Oral submucous fibrosis: an expert symposium. Oral Dis. 1997;3:276–91.

    Google Scholar 

  14. Zain RB, Gupta PC, Warnakulasuriya S, Shrestha P, Ikeda N, Axell T. Oral lesions associated with betel quid and tobacco chewing habits. Oral Dis. 1997;3(3):204–5.

    CAS  PubMed  Google Scholar 

  15. Kerr AR, Warnakulasuriya S, Mighell AJ, Dietrich T, Nasser M, Rimal J, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis. 2011;17(Sup 1):42–57.

    PubMed  Google Scholar 

  16. Gupta PC, Mehta FS, Daftary DK, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow up study of Indian villages. Community Dent Oral Epidemiol. 1980;8:287–333.

    Google Scholar 

  17. Seedat HA, van Wyk CW. Betel-nut chewing and submucous fibrosis in Durban. S Afr Med J. 1988;74:568–71.

    CAS  PubMed  Google Scholar 

  18. Tang JG, Jian XF, Gao MI, Ling TY, Zhang KH. Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunn Province, China. Community Dent Oral Epidemiol. 1997;25:177–80.

    CAS  PubMed  Google Scholar 

  19. Yang YH, Lee HY, Tung S, Shieh TY. Epidemiological survey of oral submucous fibrosis and leukoplakia in aborigines of Taiwan. J Oral Pathol Med. 2001;30:213–9.

    CAS  PubMed  Google Scholar 

  20. Bhonsle RB, Murti PR, DAftari DK, et al. Regional variations in oral submucous fibrosis in India. Community Dent Oral Epidemiol. 1987;15:225–9.

    CAS  PubMed  Google Scholar 

  21. Warnakulasuriya Warnakulasuriya KA, Ekanayake AN, Sivayoham S, Stjernswärd J, Pindborg JJ, Sobin LH, Perera KS. Utilization of primary health care workers for early detection of oral cancer and precancer cases in Sri Lanka. Bull World Health Organ. 1984;62(2):243–50.

    PubMed  Google Scholar 

  22. Su WW, Yen AM, Chiu SY, Chen TH. A community-based RCT for oral cancer screening with toluidine blue. J Dent Res. 2010;89:933–7.

    PubMed  Google Scholar 

  23. Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta HC. Oral submucous fibrosis in India: a new epidemic? Natl Med J India. 1998;11:113–6.

    CAS  PubMed  Google Scholar 

  24. Yang YH, Chen CH, Chang JS, Lin CC, Cheng TC, Shieh TY. Incidence rates of oral cancer and oral pre-cancerous lesions in a 6-year follow-up study of a Taiwanese aboriginal community. J Oral Pathol Med. 2005;34(10):596–601.

    PubMed  Google Scholar 

  25. International Agency on Research for Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 37, Tobacco habits other than smoking: betel-quid and areca nut chewing; and some related nitrosamines. Lyon: IARC; 1985.

    Google Scholar 

  26. International Agency on Research for Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 85, Tobacco habits other than smoking: betel quid and areca-nut chewing. Lyon: IARC; 2004.

    Google Scholar 

  27. International Agency on Research for Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 100E, personal habits and indoor combustion. Lyon: IARC; 2012.

    Google Scholar 

  28. Gupta PC, Warnakulasuriya S. Global epidemiology of areca nut usage. Addict Biol. 2002;7:77–83.

    CAS  PubMed  Google Scholar 

  29. Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Mehta FS. Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med. 1995;24:145–52.

    CAS  PubMed  Google Scholar 

  30. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006;42:561–8.

    CAS  PubMed  Google Scholar 

  31. Sinor PN, Gupta PC, Murti PR, et al. A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med. 1990;19:94–8.

    CAS  PubMed  Google Scholar 

  32. Hazare VK, Goel RR, Gupta PC. Oral submucous fibrosis, areca nut and pan masala use: a case-control study. Natl Med J India. 1998;11:299.

    CAS  PubMed  Google Scholar 

  33. Jacob BJ, Straif K, Thomas G, et al. Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol. 2004;40:697–704.

    PubMed  Google Scholar 

  34. Ranganathan K, Devi UM, Joshua E, Kirankumar K, Saraswathi TR. Oral submucous fibrosis: a case-control study in Chennai, South India. J Oral Pathol Med. 2004;33:274–7.

    CAS  PubMed  Google Scholar 

  35. Ahmed MS, Ali SA, Ali AS, Chaubey KK. Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India. J Indian Soc Pedod Prev Dent. 2006;24:84–9.

    Google Scholar 

  36. Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW. Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med. 1994;23:65–9.

    CAS  PubMed  Google Scholar 

  37. Ariyawardana A, Athukorala AD, Arulanandam A. Effect of betel chewing, tobacco smoking and alcohol consumption on oral submucous fibrosis: a case–control study in Sri Lanka. J Oral Pathol Med. 2006;35:197–201.

    CAS  PubMed  Google Scholar 

  38. Yang YH, Lien YC, Ho PS, et al. The effects of chewing areca/betel quid with and without cigarette smoking on oral submucous fibrosis and oral mucosal lesions. Oral Dis. 2005;11:88–94.

    PubMed  Google Scholar 

  39. Lee CH, Ko YC, Huang HL, et al. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer. 2003;88:366–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Chung CH, Yang YH, Wang TY, Shieh TY, Warnakulasuriya S. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med. 2005;34:460–6.

    PubMed  Google Scholar 

  41. Chen PC, Pan CC, Kuo C, Lin CP. Risk of oral nonmalignant lesions associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan: an integrated molecular and epidemiologic study. Arch Pathol Lab Med. 2006;130:57–61.

    PubMed  Google Scholar 

  42. Yen AM, Chen SC, Chen TH. Dose response relationship of oral habits associated with risk of oral premalignant lesions among men who chew betel quid. Oral Oncol. 2007;43:634–8.

    CAS  PubMed  Google Scholar 

  43. Babu S, Bhat RV, Kumar PU, et al. A comparative clinico-pathological study of oral submucous fibrosis in habitual chewers of pan masala and betel quid. J Toxicol Clin Toxicol. 1996;34:317–22.

    CAS  PubMed  Google Scholar 

  44. Hazarey VK, Erlewad DM, Mundhe KA, Ughade SN. Oral submucous fibrosis: study of 1000 cases from central India. J Oral Pathol Med. 2007;36:12–7.

    CAS  PubMed  Google Scholar 

  45. van Wyk CW, Staz J, Farman AG. The prevalence of oral mucosal lesions among a random sample of Asian residents in Cape Town. J Dent Assoc S Afr. 1977;32:589–92.

    PubMed  Google Scholar 

  46. Canniff JP, Harvey W, Harris M. Oral submucous fibrosis: its pathogenesis and management. Br Dent J. 1986;160(12):429–34.

    CAS  PubMed  Google Scholar 

  47. Seedat HA, van Wyk CW. Submucous fibrosis in non-betel nut chewing subjects. J Biol Buccale. 1988;16:3–6.

    CAS  PubMed  Google Scholar 

  48. Laskaris G, Bovopoulou O, Nicolis G. Oral submucous fibrosis in a Greek female. Br J Oral Surg. 1981;19:197–201.

    CAS  PubMed  Google Scholar 

  49. Simpson W. Submucous fibrosis. Br J Oral Surg. 1969;6:196–200.

    CAS  PubMed  Google Scholar 

  50. Hayes PA. Oral submucous fibrosis in a 4 year old girl. Oral Surg Oral Med Oral Pathol. 1985;59:475–8.

    CAS  PubMed  Google Scholar 

  51. Bathi RJ, Parveen S, Burde K. The role of gutka chewing in oral submucous fibrosis: a case-control study. Quintessence Int. 2009;40:e19–25.

    PubMed  Google Scholar 

  52. Huang S, Ling T, Wu H. Experimental study on aqueous areca nut extracts inducing oral submucous fibrosis in rats. I. observation of histomorphology. Hua Xi Kou Qiang Yi Xue Za Zhi. 1997;15:91–3. 96.

    CAS  PubMed  Google Scholar 

  53. Khrime RD, Mehra YN, Mann SB, Mehta SK, Chakraborti RN. Effect of instant preparation of betel nut (pan masala) on the oral mucosa of albino rats. Indian J Med Res. 1991;94:119–24.

    CAS  PubMed  Google Scholar 

  54. Sumeth Perera MW, Gunasinghe D, Perera PA, et al. Development of an in vivo mouse model to study oral submucous fibrosis. J Oral Pathol Med. 2007;36:273–80.

    CAS  PubMed  Google Scholar 

  55. Canniff JP, Harvey W. The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut. Int J Oral Surg. 1981;10:163–7.

    CAS  PubMed  Google Scholar 

  56. Harvey W, Scutt A, Meghji S, Canniff JP. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol. 1986;31:45–9.

    CAS  PubMed  Google Scholar 

  57. Jeng JH, Lan WH, Hahn LJ, Hsieh CC, Kuo MY. Inhibition of the migration, attachment, spreading, growth and collagen synthesis of human gingival fibroblasts by arecoline, a major areca alkaloid, in vitro. J Oral Pathol Med. 1996;25:371–5.

    CAS  PubMed  Google Scholar 

  58. Saraswathi TR, Sheeba T, Nalinkumar S, Ranganathan K. Effect of glutathione on area nut treated normal human buccal fibroblast culture. Indian J Dent Res. 2006;17:104–10.

    CAS  PubMed  Google Scholar 

  59. Kuo MY, Chen HM, Hahn LJ, Hsieh CC, Chiang CP. Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res. 1995;74:1783–8.

    CAS  PubMed  Google Scholar 

  60. Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder. J Oral Pathol Med. 2005;34:321–8.

    CAS  PubMed  Google Scholar 

  61. Ekanayaka RP, Tilakaratne WM. Oral submucous fibrosis: review on mechanisms of pathogenesis and malignant transformation. J Carcinog Mutagen. 2013;S5:002. doi:10.4172/2157-2518.S5-002.

    Article  Google Scholar 

  62. Roberts AB, Heine UI, Flanders KC, Sporn MB. Transforming growth factor –B; major role in regulation of extracellular matrix. Ann N Y Acad Sci. 1990;580:225–32.

    CAS  PubMed  Google Scholar 

  63. Haque MF, Harris M, Meghi S, et al. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine. 1998;10:713–9.

    CAS  PubMed  Google Scholar 

  64. Illeperuma RP, Ryu MH, Kim KY, Tilakaratne WM, Kim J. Relationship of fibrosis and the expression of TGF-β1, MMP-1, and TIMP-1 with epithelial dysplasia in oral submucous fibrosis. Oral Med Pathol. 2010;15:21–8.

    Google Scholar 

  65. Kale AD, Mane DR, Shukla D. Expression of transforming growth factor β and its correlation with lipodystrophy in oral submucous fibrosis: an immunohistochemical study. Med Oral Patol Oral Cir Bucal. 2013;18:e12–8.

    PubMed  Google Scholar 

  66. Khan I, Kumar N, Pant I, Narra S, Kondaiah P. Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis. PLoS One. 2012;7:e51806.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Moutasim KA, Jenei V, Sapienza K, et al. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol. 2011;223:366–77.

    CAS  PubMed  Google Scholar 

  68. Bishen KA, Radhakrishnan R, Satyamoorthy K. The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis. J Oral Pathol Med. 2008;37:402–11.

    PubMed  Google Scholar 

  69. Tsai CH, Yang SF, Chen YJ, Chou MY, Chang YC. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis. Oral Oncol. 2005;41:940–6.

    CAS  PubMed  Google Scholar 

  70. Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth. 2008;19:133–44.

    Google Scholar 

  71. Leask A, Sa S, Holmes A, Shiwen X, Black CM, Abraham DJ. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol. 2001;54(3):180–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Deng YT, Chen HM, Cheng SJ, Chiang CP, Kuo MY. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: modulation by curcumin. Oral Oncol. 2009;45:e99–105.

    CAS  PubMed  Google Scholar 

  73. Khan I, Agarwal P, Thangjam GS, Radhesh R, Rao SG, Kondaiah R. Role of TGF-β and BMP7 in the pathogenesis of oral submucous fibrosis. Growth Factors. 2011;29:119–27.

    CAS  PubMed  Google Scholar 

  74. Manokawinchoke J, Limjeerajarus N, Limjeerajarus C, Sastravaha P, Everts V, Pavasant P. Mechanical force–induced TGFB1 increases expression of SOST/POSTN by hPDL cells. J Dent Res. 2015;94:983–9.

    CAS  PubMed  Google Scholar 

  75. Mishra G, Ranganathan K. Matrix metalloproteinase-1 expression in oral submucous fibrosis: an immunohistochemical study. Indian J Dent Res. 2010;21:320–5.

    PubMed  Google Scholar 

  76. Pitiyage GN, Slijepcevic P, Gabrni A, et al. Senescent mesenchymal cells accumulate in human fibrosis by a telomere – independent mechanism and ameliorate fibrosis through matrix metalloproteinases. J Pathol. 2011;223:604–17.

    PubMed  Google Scholar 

  77. Pitiyage GN, Lim KP, Gemenitzidis E, et al. Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing. J Oral Pathol Med. 2012;41:454–62.

    CAS  PubMed  Google Scholar 

  78. Trivedy C, Baldwin D, Warnakulasuriya S, Johnson NW, Peters T. Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. The Lancet. 1997;349:1447.

    CAS  Google Scholar 

  79. Trivedy C, Warnakulasuriya KA, Hazarey VK, Tavassoli M, Sommer P, Johnson NW. The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med. 1999;28(6):246–51.

    CAS  PubMed  Google Scholar 

  80. Raja KB, Hazarey VK, Peters TJ, Warnakulasuriya S. Effect of areca nut on salivary copper concentration in chronic chewers. Biometals. 2007;20:43–7.

    CAS  PubMed  Google Scholar 

  81. Ayinampudi BK, Narsimhan M. Salivary copper and zinc levels in oral pre-malignant and malignant lesions. J Oral Maxillofac Pathol. 2012;16:178–82.

    PubMed  PubMed Central  Google Scholar 

  82. Trivedy C, Meghji S, Warnakulasuriya KAAS, Johnson NW, Harris M. Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med. 2001;30:465–70.

    CAS  PubMed  Google Scholar 

  83. Khanna SS, Karjodkar FR. Circulating immune complexes and trace elements (copper, iron and selenium) as markers in oral precancer and cancer: a randomised, controlled clinical trial. Head Face Med. 2006;2:33.

    PubMed  PubMed Central  Google Scholar 

  84. Tadakamadla J, Kumar S, Mamatha GP. Evaluation of serum copper and iron levels among oral submucous fibrosis patients. Med Oral Patol Oral Cir Bucal. 2011;16:e870.

    PubMed  Google Scholar 

  85. Gopal Ray J, Ranganathan K, Chattopadhyay A. Pathology of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol. 2015 (in press).

    Google Scholar 

  86. Utsunomiya H, Tilakaratne WM, Oshiro K, et al. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med. 2005;34:498–507.

    PubMed  Google Scholar 

  87. Xie H, Liu J, Ling TY. Expression of cytochrome P450 related genes in oral submucous fibrosis tissue. Zhonghua Kou Qiang Yi Xue Za Zhi. 2012;47:743–7.

    CAS  PubMed  Google Scholar 

  88. Chaudhuri SR, Mukherjee S, Paul RR, Haldar A, Chaudhuri K. CYP1AI and CYP2E1 gene polymorphisms may increase susceptibility to oral submucous fibrosis among betel quid chewers of eastern India. Gene. 2013;513:268–71.

    CAS  PubMed  Google Scholar 

  89. Ghosh T, Gupta S, Bajpai P, et al. Association of CYP1A1, GSTM1, and GSTT1 gene polymorphism with risk of oral submucous fibrosis in a section of North Indian population. Mol Biol Rep. 2012;39:9383–9.

    CAS  PubMed  Google Scholar 

  90. Shieh TM, Tu HF, Ku TH, Chang SS, Chang KW, Liu CJ. Association between lysyl oxidase polymorphisms and oral submucous fibrosis in older male areca chewers. J Oral Pathol Med. 2009;38:109–13.

    CAS  PubMed  Google Scholar 

  91. Rajendran R, Harish RK, Anil S, Vidyadharan R, Banerjee M. Transforming growth factor-β-1 polymorphisms are infrequent but exist at selected loci in oral submucous fibrosis. Indian J Dent Res. 2010;21:413–9.

    CAS  PubMed  Google Scholar 

  92. Chaudhary AK, Singh M, Bharti AC, et al. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A- > 6A) polymorphism in oral submucous fibrosis and head and neck lesions. BMC Cancer. 2010;10:369.

    PubMed  PubMed Central  Google Scholar 

  93. Chaudhary AK, Pandya S, Mehrotra R, Singh M, Singh M. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population. Biomarkers. 2011;16:577–86.

    CAS  PubMed  Google Scholar 

  94. Mukherjee S, Bhowmik AD, Roychoudhury P, Mukhopadhyay K, Ray JG, Chaudhuri K. Association of XRCC1, XRCC3, and NAT2 polymorphisms with the risk of oral submucous fibrosis among eastern Indian population. J Oral Pathol Med. 2012;41:292–302.

    CAS  PubMed  Google Scholar 

  95. Li N, Hu Q, Jiang C, et al. Novel genetic biomarkers for susceptibility to oral submucous fibrosis: cytochrome P450 3A. Med Hypotheses. 2011;77:834–6.

    CAS  PubMed  Google Scholar 

  96. Sitheeque M, Ariyawardana A, Jayasinghe R, Tilakaratne W. Depigmentation of oral mucosa as the earliest possible manifestation of oral submucous fibrosis in Sri Lankan preschool children. J Investig Clin Dent. 2010;1(2):156–9.

    PubMed  Google Scholar 

  97. Bhonsle RB, Murti PR, Daftary DK, Mehta FS. Focal vascular dilatations and petechiae in oral submucous fibrosis. Scand J Dent Res. 1981;89:270–4.

    CAS  PubMed  Google Scholar 

  98. Warnakulasuriya S. Semi-quantitative clinical description of oral submucous fibrosis. Ann Dent. 1987;46:18–21.

    CAS  PubMed  Google Scholar 

  99. Maher R, Sankaranarayanan R, Johnson NW, Warnakulasuriya KA. Evaluation of inter-incisor distance as an objective criterion of the severity of oral submucous fibrosis in Karachi, Pakistan. Oral Oncol. 1996;32B(5):362–4.

    CAS  Google Scholar 

  100. Lai DR, Chen HR, Huang YL, Tsai CC. Clinical evaluation of different treatment methods for oral submucous fibrosis: a 10 year experience with 150 cases. J Oral Pathol Med. 1995;24:402–6.

    CAS  PubMed  Google Scholar 

  101. Ranganathan K, Uma Devi M, Elizabeth J, Arun B, Rooban T, Viswanathan R. Mouth opening, cheek flexibility and tongue protrusion parameters of 800 nomal patients in Chennai, South India. A base line study to enable assessment of alterations in oral submucous fibrosis. JIDA. 2001;72:78–80.

    Google Scholar 

  102. Ranganathan K, Mishra G. An overview of classification schemes for oral submucous fibrosis. J Oral Maxillofac Pathol. 2008;10:55–8.

    Google Scholar 

  103. Hamner 3rd JE, Looney PD, Chused TM. Submucous fibrosis. Oral Surg Oral Med Oral Pathol. 1974;37(3):412–21. Review. PubMed.

    PubMed  Google Scholar 

  104. Trivedy CR, Craig G, Warnakulasuriya S. The oral health consequences of chewing areca nut. Addict Biol. 2002;7(1):115–25. Review.

    CAS  PubMed  Google Scholar 

  105. Kiran Kumar K, Saraswathi TR, Ranganathan K, Uma Devi M, Elizabeth J. Oral submucous fibrosis: a clinico-histopathological study in Chennai. Indian J Dent Res. 2007;18(3):106–11.

    CAS  PubMed  Google Scholar 

  106. Pandya S, Chaudhary AK, Singh M, Singh M, Mehrotra R. Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head Neck Oncol. 2009;1:10. doi:10.1186/1758-32.

    Article  PubMed  PubMed Central  Google Scholar 

  107. van Wyk CW, Seedat HA, Phillips VM. Collagen in submucous fibrosis: an electron-microscopic study. J Oral Pathol Med. 1990;19(4):182–7.

    PubMed  Google Scholar 

  108. El-Labban NG, Canniff JP. Ultrastructural findings of muscle degeneration in oral submucous fibrosis. J Oral Pathol. 1985;14(9):709–17.

    CAS  PubMed  Google Scholar 

  109. Jayasooriya PR, Nadeeka Jayasinghe KA, Tilakaratne WM. Relationship between thickness of fibrosis and epithelial dysplasia in oral submucous fibrosis. J Investig Clin Dent. 2011;2(3):171–5.

    PubMed  Google Scholar 

  110. Trivedy C, Warnakulasuriya KA, Tavassoli M, Steingrimsdottir H, Penhallow J, Maher R, Johnson NW. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. J Oral Pathol Med. 1998;27(2):72–7.

    CAS  PubMed  Google Scholar 

  111. Hu Y, Jian X, Peng J, Jiang X, Li N, Zhou S. Gene expression profiling of oral submucous fibrosis using oligonucleotide microarray. Oncol Rep. 2008;20:287–94.

    CAS  PubMed  Google Scholar 

  112. Hu YJ, Jian XC, Liu BJ, Peng JY. Application of bioinformatics tools in analysis of differentially expressed genes in oral submucosal fibrosis. Zhonghua Kou Qiang Yi Xue Za Zhi. 2008;43:168–71.

    PubMed  Google Scholar 

  113. Chaturvedi P, Vaishampayan SS, Nair S, et al. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease. Head Neck. 2013;35:1404–9.

    PubMed  Google Scholar 

  114. Guo F, Jian XC, Zhou SH, Li N, Hu YJ, Tang ZG. A retrospective study of oral squamous cell carcinomas originated from oral submucous fibrosis. Zhonghua Kou Qiang Yi Xue ZaZhi. 2011;46:494–7.

    Google Scholar 

  115. Yanjia H, Xinchun J. The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis. Clin Chim Acta. 2007;383:51–6.

    PubMed  Google Scholar 

  116. Tilakaratne WM, Iqbal Z, Teh MT, et al. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis. J Oral Pathol Med. 2008;37:372–7.

    CAS  PubMed  Google Scholar 

  117. Lin SC, Lo SS, Liu CJ, Chung MY, Huang JW, Chang KW. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med. 2004;33(7):405–9.

    CAS  PubMed  Google Scholar 

  118. Teh MT, Tilakaratne WM, Chaplin T, et al. Fingerprinting genomic instability in oral submucous fibrosis. J Oral Pathol Med. 2008;37:430–6.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This chapter is based on a series of papers written by the three authors in the Journal of Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Saman Warnakulasuriya .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Warnakulasuriya, S., Tilakaratne, W.M., Kerr, A. (2017). Oral Submucous Fibrosis. In: Kuriakose, M.A. (eds) Contemporary Oral Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-14911-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14911-0_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14910-3

  • Online ISBN: 978-3-319-14911-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics